The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
The Impact of Tumor Necrosis Factor α Inhibitors on Radiographic Progression in Ankylosing Spondylitis
Open accessAbstract
Objective: To study the effect of tumor necrosis factor α (TNFα) inhibitors on progressive spinal damage in patients with ankylosing spondylitis (AS). Methods: All AS patients meeting the modified New York criteria who had been monitored prospectively and had at least 2 sets of spinal radiographs a minimum of 1.5 years apart were included in the study (n = 334). The patients received standard therapy, which included nonsteroidal antiinflammatory drugs and TNFα inhibitors. Radiographic severity was assessed by the modified Stoke Ankylosing Spondylitis Spine Score (mSASSS). Patients with a rate of AS progression that was ≥1 mSASSS unit/year were considered progressors. Univariable and multivariable regression analyses were done. Propensity score matching and sensitivity analysis were performed. A zero‐inflated negative binomial (ZINB) model was used to analyze the effect of TNFα inhibitors on the change in the mSASSS with varying followup periods. Potential confounders, such as disease activity (as assessed by the Bath Ankylosing Spondylitis Disease Activity Index), the erythrocyte sedimentation rate, C‐reactive protein level, HLA–B27 positivity, sex, age at onset, smoking burden (number of pack‐years), and baseline damage, were included in the model. Results: TNFα inhibitor treatment was associated with a 50% reduction in the odds of progression, with an odds ratio (OR) of 0.52 (95% confidence interval [95% CI] 0.30–0.88, P = 0.02). Patients with a delay of >10 years in starting therapy were more likely to experience progression as compared to those who started earlier (OR 2.4 [95% CI 1.09–5.3], P = 0.03). In the ZINB model, the use of TNFα inhibitors significantly reduced disease progression when the gap between radiographs was >3.9 years. The protective effect of TNFα inhibitors was stronger after propensity score matching. Conclusion: Treatment with TNFα inhibitors appears to reduce radiographic progression in AS patients, especially with early initiation and with longer duration of followup.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Evaluation of Diagnostic Criteria for Ankylosing Spondylitis
Linden, S. V. D., Valkenburg, H. A., & Cats, A. (1984) · Arthritis & Rheumatism · doi:10.1002/art.1780270401 · Cited by 5,697
van der Heijde, D., Dijkmans, B., Geusens, P., Sieper, J., DeWoody, K., Williamson, P., & Braun, J. (2005) · Arthritis & Rheumatism · doi:10.1002/art.20852 · Cited by 860
Inman, R. D., Davis, J. C., Heijde, D. V. D., Diekman, L., Sieper, J., Kim, S. I., Mack, M., Han, J., Visvanathan, S., Xu, Z., et al. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23969 · Cited by 593
Self-citationvan der Heijde, D., Landewé, R., Einstein, S., Ory, P., Vosse, D., Ni, L., Lin, S. ‐., Tsuji, W., & Davis, J. C. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23471 · Cited by 549
Heijde, D. V. D., Landewé, R., Baraliakos, X., Houben, H., Tubergen, A. V., Williamson, P., Xu, W., Baker, D., Goldstein, N., & Braun, J. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23901 · Cited by 514
van der Heijde, D., Salonen, D., Weissman, B. N., Landewé, R., Maksymowych, W. P., Kupper, H., Ballal, S., Gibson, E., Wong, R., & the Canadian (M03-606) study group and the ATLAS study group (2009) · Arthritis Research & Therapy · doi:10.1186/ar2794 · Cited by 413
Poddubnyy, D., Rudwaleit, M., Haibel, H., Listing, J., Märker-Hermann, E., Zeidler, H., Braun, J., & Sieper, J. (2012) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2011-201252 · Cited by 337
Landewé, R., Dougados, M., Mielants, H., van der Tempel, H., & van der Heijde, D. M. F. M. (2008) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2008.091793 · Cited by 276
The outcome of ankylosing spondylitis: a study of 100 patients.
Gran, J. T., & Skomsvoll, J. F. (1997) · Rheumatology · doi:10.1093/rheumatology/36.7.766 · Cited by 276
Are there gender differences in severity of ankylosing spondylitis? Results from the PSOAS cohort
Lee, W., Reveille, J. D., Davis, J. C., Learch, T. J., Ward, M. M., & Weisman, M. H. (2007) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2006.060293 · Cited by 273
Self-citation
Cited by
Sieper, J., & Poddubnyy, D. (2017) · The Lancet · doi:10.1016/s0140-6736(16)31591-4 · Cited by 1,333
Ankylosing Spondylitis and Axial Spondyloarthritis
Taurog, J. D., Chhabra, A., & Colbert, R. A. (2016) · New England Journal of Medicine · doi:10.1056/nejmra1406182 · Cited by 900
Jacques, P., Lambrecht, S., Verheugen, E., Pauwels, E., Kollias, G., Armaka, M., Verhoye, M., Van der Linden, A., Achten, R., Lories, R. J., et al. (2014) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2013-203643 · Cited by 431
Braun, J., Baraliakos, X., Deodhar, A., Baeten, D., Sieper, J., Emery, P., Readie, A., Martin, R., Mpofu, S., & Richards, H. B. (2017) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2016-209730 · Cited by 273
Haroon, N. N., Paterson, J. M., Li, P., Inman, R. D., & Haroon, N. (2015) · Annals of Internal Medicine · doi:10.7326/m14-2470 · Cited by 261
Self-citation
Metadata
- Authors
- Haroon, N., Inman, R. D., Learch, T. J., Weisman, M. H., Lee, M., Rahbar, M. H., Ward, M. M., Reveille, J. D., & Gensler, L. S.
- Venue
- Arthritis & Rheumatism
- Publisher
- Wiley
- Published
- 2013-09-24
- Volume
- 65
- Issue
- 10
- Pages
- 2645-2654
- ISSN
- 0004-3591 (ISSN-L)
- 1529-0131
- OpenAlex
- W1621490964
- Cited by
- 490
- References
- 18
- FWCI
- 38.28
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Impact of Tumor Necrosis Factor α Inhibitors on Radiographic Progression in Ankylosing Spondylitis. https://app.cochat.ai/papers/10.1002/art.38070
- The paper
- Haroon, N., Inman, R. D., Learch, T. J., Weisman, M. H., Lee, M., Rahbar, M. H., Ward, M. M., Reveille, J. D., & Gensler, L. S. (2013). The Impact of Tumor Necrosis Factor α Inhibitors on Radiographic Progression in Ankylosing Spondylitis. Arthritis & Rheumatism. https://doi.org/10.1002/art.38070
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.